Skip to main content

The Global Anxiety Disorder Treatment Market Share to Witness Major Growth

 Market Forecast

People with anxiety disorders may feel anxious most of the time or for the brief, intense episodes, which may occur for no apparent reason. The main categories of anxiety disorders include phobia, panic disorder, generalized anxiety disorder, social anxiety disorder, selective mutism, and separation anxiety disorder.

Numerous established players dominate the Anxiety Disorder Treatment Market share. The key players are involved in strategic initiatives to strengthen their market positions and expand their geographic presence in developing regions. Many players are investing in research activities to develop effective therapies to sustain in the market. For instance, Eli Lilly and Company launched Duloxetine and Forest Laboratories, Inc. launched Vilazodone, used for the treatment of generalized anxiety disorder.

Market Influencers

Strategic initiatives, mergers & acquisitions, partnerships, agreements, product launches, government approvals, and expansion of manufacturing facilities by major key players are positively influencing the market.

Regional Analysis

On a regional basis, the Americas is anticipated to dominate the global anxiety disorder treatment market owing to the rising incidence of anxiety disorders in the region. For instance, generalized anxiety disorder affects 6.8 million adults, or 3.1% of the US population every year. Moreover, rising awareness campaigns regarding the anxiety disorders by the government and public organizations is driving the growth of the market in this region. For instance, the Anxiety and Depression Association of America (ADAA) started an initiative named BreaktheStigma. This campaign raises awareness regarding mental illness and end stigma and creates hope for those affected by mental illness.

Europe is expected to hold the second-largest position in the global anxiety disorder treatment market owing to supportive government policies and raising public awareness about anxiety disorder treatments.

Asia-Pacific is anticipated to be the fastest-growing region is due to the growing prevalence of psychological conditions such as anxiety disorders, rising interest of major key players in emerging markets, good quality healthcare infrastructure in this region. The Middle East & Africa has the least share of the global anxiety disorder treatment market. This is attributable to limited healthcare infrastructure and a lack of awareness about anxiety disorder treatments in this region.

Segmentation

The Global Anxiety Disorder Treatment Market has been segmented into drug class and end-user.

By drug class, the market has been segmented into SSRIs (selective serotonin reuptake inhibitors), SNRIs (serotonin-norepinephrine reuptake inhibitors), TCAs (tricyclic antidepressants),      pregabalin, buspirone, benzodiazepines, and others.

The global anxiety disorder treatment market, by end-user, has been segmented into hospitals, mental healthcare centers, asylums, and others.

Key Players

The leading players mentioned in the Anxiety Disorder Treatment Market trends report are

  • Bristol-Myers Squibb Company (US)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • AstraZeneca PLC (UK)
  • Sanofi-Aventis (France)
  • Forest Laboratories, Inc. (US)
  • Pfizer, Inc. (US)
  • GlaxoSmithKline PLC (UK)
  • Lundbeck A/S (Denmark)
  • Merck & Co., Inc. (US)

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Live Attenuated Vaccines Market Share of Top Key Players 2022-2030 with Industry Growth

 The live attenuated vaccines (LAV) market is growing at a rapid pace, mainly due to the increasing prevalence of bacterial and viral diseases. Moreover, rapidly spreading awareness towards the healthcare and the availability of various effective vaccines are escalating the market on the furthering heights. Acknowledging the exponential accruals, the market witnesses today, Market Research Future (MRFR) in its recently published a study report asserts that the global  live attenuated vaccines market share  will reach USD 42,645.5 MN by 2030 with a CAGR of approximately 12.3% during the forecast period (2022-2030). Initiatives taken by the governments for vaccination against diseases such as influenza and others, alongside the excellent management of public awareness programs are some of the major driving forces behind the accelerating market growth. Furthermore, increasing awareness about vaccination, and growing government funding for vaccination programs along with the increasing pre
Post a Comment
Read more

Global Rabies Diagnostics Market Share 2022-2030 including Industry Size, Trends & Growth

  The global rabies diagnostics market share is growing pervasively, mainly due to the increasing prevalence of rabies. Besides, spreading awareness of diagnostic procedures is driving the growth of the market. Also, rising research and development activities by non-profit organizations alongside, the aggressive strategies by top players such as mergers & acquisition, expansion, and collaboration for the development of new products and launches are accelerating the growth of the market on a global level. According to a leading research firm Market Research Future (MRFR), the global rabies diagnostics market is expected to further appreciate at a CAGR of 3.90% throughout the forecast period (2022–2030). In its analysis, MRFR asserts that the market will perceive phenomenal accruals by 2030. The major outburst of the rabies virus, mainly in various regions across the globe is a significant driving force for the market. Governments, across the world, have taken up various initiat
Post a Comment
Read more

Global Nanomedicine Market Share Growth Driven by Growing Number of Venture Capital Investors

  Market Highlights According to MRFR analysis, the global nanomedicine market share is expected to register a CAGR of ~9.2% from 2022 to 2030 and hold a value of USD 393,040 million by 2030. Nanomedicine is one of the nanotechnology applications used to diagnose, treat, monitor, and control biological systems. Nanomedicine is the use of nanoscale material manipulation to improve medicine delivery. Nanomedicine has the potential to enhance early detection, prevention, diagnosis, therapy, and follow-up for a wide range of illnesses, including cancer. Hundreds of nanomedicine products are now being tested in clinical trials, covering all major cardiovascular, neurological, inflammatory, and musculoskeletal illnesses. With over 80 commercialized products spanning from nano-delivery and medications to medical imaging, biomaterials, and diagnostics, nanomedicine is an enabling technology in all healthcare disciplines. For instance, according to Alzheimer's Disease International, there
Post a Comment
Read more